Atossa Therapeutics
(NASDAQ:ATOS)
Atossa Therapeutics, Inc. - Common Stock is expected to split Monday, August 15, 2022 with a ratio of 1:5
Atossa Therapeutics, Inc. - Common Stock recently split on Friday, August 12, 2022 with a ratio of 1:3
$1.08
0.03[2.86%]
At close: Aug 12
$1.05
-0.0300[-2.78%]
After Hours: 6:33PM EDT
Day High/Low1.04 - 1.09
52 Week High/Low0.84 - 1.8
Open / Close1.05 / 1.08
Float / Outstanding126.6M / 126.6M
Vol / Avg.765.2K / 1.3M
Mkt Cap136.8M
P/E-
50d Avg. Price1.05
Div / Yield-
Payout Ratio-
EPS-0.04
Total Float126.6M

Atossa Therapeutics (NASDAQ:ATOS), Quotes and News Summary

Atossa Therapeutics (NASDAQ: ATOS)

Day High/Low1.04 - 1.09
52 Week High/Low0.84 - 1.8
Open / Close1.05 / 1.08
Float / Outstanding126.6M / 126.6M
Vol / Avg.765.2K / 1.3M
Mkt Cap136.8M
P/E-
50d Avg. Price1.05
Div / Yield-
Payout Ratio-
EPS-0.04
Total Float126.6M
Sector: Health Care.Industry: Biotechnology
Atossa Therapeutics Inc is a clinical-stage pharmaceutical company operating in us. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

Earnings

see more
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-12-20
REV
FY 2023Est.ActualSurprise
EPS
(EXPECTED)2023-11-09
REV

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Atossa Therapeutics Questions & Answers

Q
How do I buy Atossa Therapeutics (ATOS) stock?
A

You can purchase shares of Atossa Therapeutics (NASDAQ: ATOS) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Atossa Therapeutics's (ATOS) competitors?
Q
What is the target price for Atossa Therapeutics (ATOS) stock?
A

The latest price target for Atossa Therapeutics (NASDAQ: ATOS) was reported by Cantor Fitzgerald on Friday, August 12, 2022. The analyst firm set a price target for 4.00 expecting ATOS to rise to within 12 months (a possible 270.37% upside). 50 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Atossa Therapeutics (ATOS)?
A

The stock price for Atossa Therapeutics (NASDAQ: ATOS) is $1.08 last updated August 12, 2022, 8:00 PM UTC.

Q
Does Atossa Therapeutics (ATOS) pay a dividend?
A

The next Atossa Therapeutics (ATOS) dividend date is projected to be Thursday, September 1, 2022.

Q
When is Atossa Therapeutics (NASDAQ:ATOS) reporting earnings?
A

Atossa Therapeutics’s FY earnings are confirmed for Wednesday, December 20, 2023.

Q
Is Atossa Therapeutics (ATOS) going to split?
A

There is no upcoming split for Atossa Therapeutics.

Q
What sector and industry does Atossa Therapeutics (ATOS) operate in?
A

Atossa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.